ivermectin
Selected indexed studies
- Ivermectin, a potential anticancer drug derived from an antiparasitic drug. (Pharmacol Res, 2021) [PMID:32971268]
- Ivermectin: a mini-review. (Clin Toxicol (Phila), 2022) [PMID:35225114]
- Ivermectin for preventing and treating COVID-19. (Cochrane Database Syst Rev, 2022) [PMID:35726131]
_Worker-drafted node — pending editorial review._
Connections
ivermectin is a side effect of
Sources
- Ivermectin, a potential anticancer drug derived from an antiparasitic drug. (2021) pubmed
- Ivermectin: a mini-review. (2022) pubmed
- Ivermectin for preventing and treating COVID-19. (2022) pubmed
- Ivermectin in Cancer Treatment: Should Healthcare Providers Caution or Explore Its Therapeutic Potential? (2025) pubmed
- Ivermectin and non-parasitic disorders: An update. (2025) pubmed
- Ivermectin and moxidectin against soil-transmitted helminth infections. (2023) pubmed
- [Ivermectin]. (2004) pubmed
- Ivermectin for preventing and treating COVID-19. (2021) pubmed
- Ivermectin's Role in the Prevention of COVID-19: A Systematic Review and Meta-Analysis. (2023) pubmed
- Ivermectin in dermatology. (2003) pubmed